BR9914161A - Métodos para detectar a presença de células de câncer de mama e de células de câncer endometrial e a presença de câncer de mama e de câncer endometrial em um paciente e kits para detectar a presença de células de neoplasia de mama e a presença de câncer de mama em uma amostra - Google Patents

Métodos para detectar a presença de células de câncer de mama e de células de câncer endometrial e a presença de câncer de mama e de câncer endometrial em um paciente e kits para detectar a presença de células de neoplasia de mama e a presença de câncer de mama em uma amostra

Info

Publication number
BR9914161A
BR9914161A BR9914161-2A BR9914161A BR9914161A BR 9914161 A BR9914161 A BR 9914161A BR 9914161 A BR9914161 A BR 9914161A BR 9914161 A BR9914161 A BR 9914161A
Authority
BR
Brazil
Prior art keywords
breast cancer
cancer cells
methods
detect
cells
Prior art date
Application number
BR9914161-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Mark A Watson
Timothy P Fleming
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of BR9914161A publication Critical patent/BR9914161A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR9914161-2A 1998-09-29 1999-09-29 Métodos para detectar a presença de células de câncer de mama e de células de câncer endometrial e a presença de câncer de mama e de câncer endometrial em um paciente e kits para detectar a presença de células de neoplasia de mama e a presença de câncer de mama em uma amostra BR9914161A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/162,622 US6566072B1 (en) 1995-05-31 1998-09-29 Mammaglobin, a secreted mammary-specific breast cancer protein
PCT/US1999/022616 WO2000018783A1 (en) 1998-09-29 1999-09-29 Mammaglobin, a secreted mammary-specific breast cancer protein

Publications (1)

Publication Number Publication Date
BR9914161A true BR9914161A (pt) 2001-06-26

Family

ID=22586430

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914161-2A BR9914161A (pt) 1998-09-29 1999-09-29 Métodos para detectar a presença de células de câncer de mama e de células de câncer endometrial e a presença de câncer de mama e de câncer endometrial em um paciente e kits para detectar a presença de células de neoplasia de mama e a presença de câncer de mama em uma amostra

Country Status (15)

Country Link
US (1) US6566072B1 (cg-RX-API-DMAC7.html)
EP (1) EP1117673A4 (cg-RX-API-DMAC7.html)
JP (1) JP2002525098A (cg-RX-API-DMAC7.html)
KR (1) KR20010075418A (cg-RX-API-DMAC7.html)
CN (1) CN1328567A (cg-RX-API-DMAC7.html)
BR (1) BR9914161A (cg-RX-API-DMAC7.html)
CA (1) CA2343980C (cg-RX-API-DMAC7.html)
CZ (1) CZ20011025A3 (cg-RX-API-DMAC7.html)
HU (1) HUP0104408A3 (cg-RX-API-DMAC7.html)
IL (1) IL142079A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA01003240A (cg-RX-API-DMAC7.html)
NO (1) NO20011394L (cg-RX-API-DMAC7.html)
PL (1) PL347021A1 (cg-RX-API-DMAC7.html)
TR (1) TR200101702T2 (cg-RX-API-DMAC7.html)
WO (1) WO2000018783A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7009042B1 (en) * 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
EP1517913B9 (en) * 1999-10-07 2007-08-29 Corixa Corporation A mycobacterium tuberculosis coding sequence for exression of heterologous proteins
US7250496B2 (en) * 2002-11-14 2007-07-31 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory genes and uses thereof
CN100577815C (zh) * 2003-05-01 2010-01-06 维里德克斯有限责任公司 手术中的淋巴结检测
US7662580B2 (en) * 2005-11-10 2010-02-16 Aurelium Biopharma Inc. Tissue diagnostics for breast cancer
US8795359B2 (en) 2012-06-13 2014-08-05 Elwha Llc Breast implant with regionalized analyte sensors and internal power source
US8808373B2 (en) 2012-06-13 2014-08-19 Elwha Llc Breast implant with regionalized analyte sensors responsive to external power source
US9144488B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with analyte sensors responsive to external power source
US8790400B2 (en) 2012-06-13 2014-07-29 Elwha Llc Breast implant with covering and analyte sensors responsive to external power source
US9144489B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with covering, analyte sensors and internal power source
US9211185B2 (en) 2012-06-13 2015-12-15 Elwha Llc Breast implant with analyte sensors and internal power source
CN105548364B (zh) * 2015-12-10 2018-11-02 北京理工大学 热障涂层结合强度的高阶非线性参数表征方法
EP3699595A1 (en) * 2019-02-22 2020-08-26 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Use of bmmf1 rep protein as a biomarker for breast cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US5573916A (en) 1994-05-19 1996-11-12 Coretech, Inc. Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
US5668267A (en) 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens
WO1998007753A1 (en) * 1996-08-19 1998-02-26 Abbott Laboratories Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast
WO1998021331A1 (en) * 1996-11-12 1998-05-22 Incyte Pharmaceuticals, Inc. Human breast tumor-specific proteins

Also Published As

Publication number Publication date
TR200101702T2 (tr) 2001-12-21
MXPA01003240A (es) 2003-06-24
PL347021A1 (en) 2002-03-11
US6566072B1 (en) 2003-05-20
EP1117673A1 (en) 2001-07-25
IL142079A0 (en) 2002-03-10
EP1117673A4 (en) 2004-08-04
WO2000018783A1 (en) 2000-04-06
NO20011394D0 (no) 2001-03-19
KR20010075418A (ko) 2001-08-09
JP2002525098A (ja) 2002-08-13
HUP0104408A2 (hu) 2002-03-28
CZ20011025A3 (cs) 2001-09-12
CA2343980C (en) 2012-06-26
CN1328567A (zh) 2001-12-26
NO20011394L (no) 2001-05-22
WO2000018783A9 (en) 2000-09-21
WO2000018783B1 (en) 2000-05-11
CA2343980A1 (en) 2000-04-06
HUP0104408A3 (en) 2007-05-02

Similar Documents

Publication Publication Date Title
BR9812472A (pt) Vacina especìfica de mamaglobina, processo para tratar um paciente com um tumor que expressa mamaglobina, e, polipeptìdeo isolado e purificado
AU2001253079A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
BR0009537A (pt) Composições para tratamento e diagnóstico de câncer de mama e métodos para seu uso
Karjalainen et al. Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma
BRPI0410842A (pt) variantes de antìgenos de células tronco de próstata (psca) e sub-seqüências das mesmas
ES2032468T3 (es) Procedimiento para la preparacion de reactivos inmunologicos para la deteccion y eliminacion de celulas dianas especificas.
BR9609270A (pt) Polinucleotídeo isolado e purificado peptídeo isolado e purificado processo para detectar a presença da câncer mamário em um paciente e kit para a detecção da presença de células neoplásticas mamárias em uma amostra
AU1726199A (en) Metastatic cancer regulated gene
ATE229073T1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
DE60045201D1 (de) C-Typ-Lektin-Transmembran-Antigen, das in menschlichem Prostatakrebs exprimiert wird, und Verwendungen dieses Antigens
WO2005040421A3 (en) Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues
BR0012069A (pt) Composições e métodos para a terapia e diagnóstico de câncer pulmonar
WO2002083070A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
BR0112542A (pt) Composições e métodos papa a terapia e a diagnose de câncer ovariano
HUP0301740A2 (hu) Emlőrák kezelésére és diagnosztizálására szolgáló készítmények és eljárások
DE60135315D1 (de) In brust- und blasenkrebs differentiell exprimiertes gen und durch dieses kodierte polypeptide
Oka et al. c‐erbB‐2 oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix
WO2008012362A3 (en) New protein isoforms and uses thereof
WO1999058978A3 (en) Tumour markers
WO2003069307A3 (en) Claudins, markers for diagnosis, prognosis and therapy of breast, bone, brain cancer
TR200101702T2 (tr) Mammaglobin, göğse özgü salgılanan bir göğüs kanseri proteini.
DK0454782T3 (da) Cancer-beslægtet haptaglobin (Hpr.)
BR0009573A (pt) Composições e métodos para o tratamento e diagnose do câncer de mama
ATE266203T1 (de) Methode zur identifizierung von tumorantigenen mit autoantikörpern in serum
BRPI0511624A (pt) anticorpos e moléculas relacionadas que se ligam à proteìnas psca

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]